Archives biogen

by in
Entry Author Date Location
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy 07/02/15 Boston
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
Adaptive Reels in Whopping $195M For Immuno-Sequencing Work 05/06/15 Seattle
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers 04/21/15 Boston
What’s Hot in Boston Biotech? Here’s the Agenda 03/26/15 Boston
Amid Gene Editing Worry, A Return To Biotech’s 1st “Asilomar Moment” 03/26/15 Boston
Cubist CEO Bonney Steps Down After 12-Year Stint 10/20/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Remembering James L. Vincent, Longtime Biogen Leader 12/31/13 Boston
Juan Enriquez, Mark Levin, Phil Sharp to Speak at Healthcare Summit Oct. 15 09/10/13 Boston
Kendall Square’s New Rules 04/23/13 Boston
See You Today at New England’s Emerging Biotech Stars***SOLD OUT*** 04/04/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
Will New Business Models Enhance or Endanger Drug Discovery? 02/16/12 National
XSITE 2011: The Entrepreneurship Era. The Day in Pictures 06/21/11 Boston
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders 06/02/11 Boston
Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters 05/26/11 Boston
David Cancel, Stephen Kaufer, Katie Rae, and Others Join XSITE Program on June 16 04/28/11 Boston
What do Desh Deshpande, Gilt Groupe, Nobelist Phil Sharp, & Intellectual Ventures Have in Common? All Are Keynoting at XSITE 2011-The Entrepreneurship Era 04/20/11 Boston
Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News 02/26/10 Boston
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney 10/14/09 Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1 07/27/09 Seattle
Biogen Gets Int’l Rights to Acorda’s MS Drug 07/01/09 Boston
Biogen Reports 10th PML Case in Tysabri Patient 06/29/09 Boston
EMD Serono Staging Battle Against Multiple Sclerosis in Boston, Chief Says 06/08/09 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments 10/24/08 San Diego
Page 1 of 2 next page »